Covaxin gets DCGI nod for emergency use for kids aged 12-18 years

Indigenously developed Covid-19 vaccine Covaxin has received approval from the Drugs Controller General of India (DCGI) for emergency use in children aged between 12-18 years. The drug regulator’s nod comes over two months after the Subject Expert Committee (SEC), that advises the DCGI, recommended emergency use approval for vaccinating kids in the 2-18 years age group.